<< Read Full Article

This Is No Time to Be Buying Pfizer

 

OK, Pfizer(PFE Quote) is the pharmaceutical company I admire above all others (if you don't count Merck(MRK Quote) for its extraordinarily generous history of donating vaccines).

Pfizer does great research (it should, considering the company'll spend $4.8 billion on it this year). The head of research and development, George Milne, is a thoughtful, strategic-thinking kind of guy. In the past few years, when several heads of research at pharma companies were thrown overboard, George kept Pfizer on an admirably steady course.

I also believe Pfizer does the best job of all the big pharmas at partnering with other companies. This is important because drug development is like wildcat oil drilling -- you never know when you'll strike a gusher. Mind you, Pfizer used to talk about "Pfizergen," its umbrella effort at partnering with other companies, particularly biotech companies.

...

<< Read Full Article

Recent Comments

Loading .....




Dow Jones S&P 500 NASDAQ 10-Year Note
10,454.65 1,111.05 2,209.68 35.96
Oil *
73.55
UP
2.65
UP
3.12
UP
8.63
DOWN
0.07
10 Yr
3.60%
SPDR Gold
110.93
+0.03%
+0.28%
+0.39%
-0.19%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services